https://mazenz.com/Newsemia/2020/01/29/tumor-time-course-predicts-overall-survival-in-non-small-cell-lung-cancer-patients-treated-with-atezolizumab-dependency-on-follow-up-time/
Tumor Time-Course Predicts Overall Survival in Non-Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow-Up Time.